Evidence map›Paper›PMID 35188955›Full record

ArticleBrain : a journal of neurology2023

Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia.

Golia Shafiei, Vincent Bazinet, Mahsa Dadar, Ana L Manera, D Louis Collins, Alain Dagher, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Robert Laforce and 25 more

Open access · greenAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 83 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Emerging directions in tauopathy research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  8. Article
  9. Structure-function coupling in the human brainstem.bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 20 institutions in 8 countries.

Golia ShafieiMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-2036-5571
Vincent BazinetMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Mahsa DadarMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0003-4008-2672
Ana L ManeraMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
D Louis CollinsMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-8432-7021
Alain DagherMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-0945-5779
Barbara BorroniCentre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Raquel Sanchez-ValleAlzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.ORCID 0000-0001-7750-896X
Fermin MorenoCognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.
Robert LaforceClinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, CHU de Québec, and Faculté de Médecine, Université Laval, Quebec, QC, Canada.
Caroline GraffDepartment of Geriatric Medicine, Karolinska University Hospital-Huddinge, Stockholm, Sweden.ORCID 0000-0002-9949-2951
Matthis SynofzikDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-2280-7273
Daniela GalimbertiFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy.
James B RoweUniversity of Cambridge, Department of Clinical Neurosciences, Cambridge University Hospitals NHS Trust, and MRC Cognition and Brain Sciences Unit, Cambridge, UK.
Mario MasellisSunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-6244-2096
Maria Carmela TartagliaToronto Western Hospital, Tanz Centre for Research in Neurodegenerative Disease, Toronto, ON, Canada.
Elizabeth FingerDepartment of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada.
Rik VandenbergheLaboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Alexandre de MendonçaFaculty of Medicine, University of Lisbon, Lisbon, Portugal.
Fabrizio TagliaviniFondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milan, Italy.
Isabel SantanaNeurology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Chris ButlerDepartment of Clinical Neurology, University of Oxford, Oxford, UK.
Alex GerhardDivision of Neuroscience and Experimental Psychology, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.
Adrian DanekDepartment of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.
Johannes LevinDepartment of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.
Markus OttoDepartment of Neurology, University Hospital Ulm, Ulm, Germany.
Sandro SorbiDepartment of Neurofarba, University of Florence, Florence, Italy.
Lize C JiskootDepartment of Neurology, Erasmus University Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0002-8120-7366
Harro SeelaarDepartment of Neurology, Erasmus University Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0003-1989-7527
John C van SwietenDepartment of Neurology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Jonathan D RohrerDepartment of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.
Bratislav MisicMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0003-0307-2862
Simon DucharmeMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-7309-1113
Frontotemporal Lobar Degeneration Neuroimaging Initiative (FTLDNI)
GENetic Frontotemporal dementia Initiative (GENFI)
Montreal Neurological Institute and Hospital · CAGerman Center for Neurodegenerative Diseases · DEHospitais da Universidade de Coimbra · PTKarolinska University Hospital · SEBiogipuzkoa Health Research Institute · ESDon Carlo Gnocchi Foundation · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITLudwig-Maximilians-Universität München · DEMRC Cognition and Brain Sciences Unit · GBSunnybrook Health Science Centre · CAToronto Western Hospital · CAUK Dementia Research Institute · GBUniversitat de Barcelona · ESUniversité Laval · CAUniversity Hospital Ulm · DEUniversity of Brescia · ITUniversity of Lisbon · PTUniversity of Manchester · GBUniversity of Milan · ITUniversity of Oxford · GB

Funding

The Frontotemporal Lobar Degeneration Neuroimaging InitiativeR01AG032306 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSEN, HOWARD J · 2009 to 2013
$10.0M
Canada Research Chairs ProgramFonds de recherche du QuébecFonds de recherche du Québec-Nature et TechnologiesFonds de Recherche du Québec-Santé (FRQS)Frontotemporal Lobar Degeneration Neuroimaging InitiativeMedical Research Council MR/J009482/1Medical Research Council MR/M008525/1Medical Research Council MR/M023664/1Medical Research Council MR/T046015/1Natural Sciences and Engineering Research Council of Canada #017-04265NIA NIH HHS R01 AG032306NIH HHS R01 AG032306University of California, San FranciscoUniversity of Southern California
6 · The paper itself

Abstract

Connections among brain regions allow pathological perturbations to spread from a single source region to multiple regions. Patterns of neurodegeneration in multiple diseases, including behavioural variant of frontotemporal dementia (bvFTD), resemble the large-scale functional systems, but how bvFTD-related atrophy patterns relate to structural network organization remains unknown. Here we investigate whether neurodegeneration patterns in sporadic and genetic bvFTD are conditioned by connectome architecture. Regional atrophy patterns were estimated in both genetic bvFTD (75 patients, 247 controls) and sporadic bvFTD (70 patients, 123 controls). First, we identified distributed atrophy patterns in bvFTD, mainly targeting areas associated with the limbic intrinsic network and insular cytoarchitectonic class. Regional atrophy was significantly correlated with atrophy of structurally- and functionally-connected neighbours, demonstrating that network structure shapes atrophy patterns. The anterior insula was identified as the predominant group epicentre of brain atrophy using data-driven and simulation-based methods, with some secondary regions in frontal ventromedial and antero-medial temporal areas. We found that FTD-related genes, namely C9orf72 and TARDBP, confer local transcriptomic vulnerability to the disease, modulating the propagation of pathology through the connectome. Collectively, our results demonstrate that atrophy patterns in sporadic and genetic bvFTD are jointly shaped by global connectome architecture and local transcriptomic vulnerability, providing an explanation as to how heterogenous pathological entities can lead to the same clinical syndrome.

Indexed as

ConnectomeFrontotemporal DementiaPick Disease of the BrainAtrophyBrainHumansMagnetic Resonance ImagingNeuropsychological TestsTranscriptomeconnectomedisease epicentrefrontotemporal dementiagene expressionnetwork spreading

Identifiers

PMID35188955
PMCPMC9825569
OpenAlexW4212965895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.